Opioids Market Size, Share, and Growth Overview by 2031
The opioids market size is projected to reach US$ 15.03 billion by 2031 from US$ 12.93 billion in 2023. The market is expected to register a CAGR of 1.9% in 2023–2031. Key factors driving the market growth include surging chronic pain incidences and an increasing geriatric population across the world.
Opioids Market Analysis
Chronic diseases such as cardiovascular disease, cancer, musculoskeletal diseases, and neurovascular diseases critically affect a person's health by lowering immunity. Moreover, many patients suffering from these conditions experience chronic pain. The diseases mentioned above are most common in adults and the geriatric population. Nevertheless, cases of these diseases are noticeably growing among children as well. Chronic pain is also common among sportspersons, athletes, and individuals living with past injuries. In 2021, the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention (CDC) reported that chronic pain affects ~20% of adults in the US. The advantage of opioids in pain management propels their demand in chronic disease management procedures.
Opioids Market Overview
The surging incidence of chronic pain and the increasing geriatric population are the main factors contributing to the expansion of the opioid market. According to the Congressional Research Service, Americans may get more opioids at the expense of more comprehensive pain therapies. Increased opioid prescribing practices can be attributed to the insurance reimbursement programs that incentivize opioids over alternative pain treatments, cost structures that encourage more efficient care, and evaluations that combine patient satisfaction with effective pain management. Therefore, owing to the advantage of opioids in pain management, the demand is rising among patients with chronic diseases.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Opioids Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Opioids Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Opioids Market Drivers and Opportunities
Rising Geriatric Population Favors Opioids Market Progress
The majority of older people live with chronic pain, resulting in reduced strength to carry out their daily activities. The elderly population widely suffers from bone and joint disorders, arthritis, cancer, and other chronic disorders causing pain. According to the World Health Organization (WHO) data from February 2018, the geriatric population is estimated to grow by 22% by 2050 compared with 12% in 2015. The data also stated that low- and middle-income countries would account for nearly 80% of this surge. Developed countries such as the US, Canada, the UK, France, Germany, and Japan, and developing countries such as China, India, and South Korea are also experiencing significant growth in the geriatric population. Thus, the increasing geriatric population is the major driver of the growth of the opioid market across the world.
Strategic Initiatives by Market Players – An Opportunity in Customization of the Opioid market
Opioid market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency.
Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.
Opioids Market Report Segmentation Analysis
Key segments that contributed to the derivation of the opioids Market analysis are type, cause, disorder type, category, and end user.
- Based on type, the opioids market is divided into immediate-release short-acting opioids and extended-release long-acting opioids. The immediate-release short-acting opioids segment held a larger market share in 2023. This same segment is expected to record a higher CAGR during 2023–2031.
- By application, the market is classified into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management segment held the largest share of the market in 2023.
- In terms of the route of administration, the market is classified into intravenous, oral administration, and patch. The oral segment held the largest share of the market in 2023.
- By end user, the market is divided into hospital pharmacies and clinical pharmacies. The hospital pharmacy segment accounted for a larger share of the opioids market in 2023.
Opioids Market Share Analysis, by Geography
The geographic scope of the opioids market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America dominated the opioid market in 2023. The surging cases of opioid overdose are affecting the growth of the opioid market. As per the World Health Organization (WHO) statistics on opioid overdose, there were 70,630 deaths due to drug overdose in 2019 in the US. The CDC also estimated that ~280,000 people in the country died from the overdose of prescription opioids during 1999–2021. The presence of global market players is another noteworthy factor contributing to the dominance of North America in the global opioids market. Asia Pacific is anticipated to record the highest CAGR in the market in the coming years.
Opioids Market Report Scope
Opioids Market News and Recent Developments
The opioids market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments and strategies in the opioids market:
- In March 2023, Trevena, Inc. announced that Jiangsu Nhwa Pharmaceutical Co., its partner in China, received formal approval from the National Medical Products Administration for OLINVYK. It has been approved for use in adults for the management of acute pain that is severe enough to require an intravenous opioid analgesic and is resistant to alternative treatments. (Source: Trevena, Inc., Press Release, 2023)
- In January 2023, Neuraxpharm announced the establishment of Neuraxpharm Belgium to cover Belgium and Luxembourg, completing its presence in Benelux as it continues its expansion pathway in Europe. (Source: Neuraxpharm, Press Release, 2023)
- In February 2023, Neuraxpharm announced the acquisition of two established product portfolios for central nervous system (CNS) disorders, and pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired include 15 products addressing CNS disorders and 2 products in pain and vascular diseases. (Source: Neuraxpharm, Press Release, 2023)
Opioids Market Report Coverage and Deliverables
The “Opioid Market Size and Forecast (2023–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST and SWOT analyses
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments.
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The opioids market, by application, is segmented into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management held the largest share of the market in 2023. The de-addiction segment is anticipated to register the highest CAGR of 2.4% during the forecast period.
The opioids market was valued at US$ 12.93 billion in 2023.
The opioids market is expected to be valued at US$ 15.03 million in 2031.
The opioids market, by product, is segmented into immediate-release short-acting opioids and extended-release long-acting opioids. The immediate release short acting opioid segment held a larger share of the market in 2023. It is further anticipated to register a higher CAGR of 2.0% in the market during the forecast period.
Surging chronic pain incidences and increasing geriatric population are the major driving factor promoting the growth of the market. However, increasing drug abuse hinders the market opioid marjet growth.
The opioids market majorly consists of the players, including Purdue Pharma LP, Endo International plc, Mallinckrodt Plc, Collegium Pharmaceutical Inc, Neuraxpharm Pharmaceuticals SL, Hikma Pharmaceuticals Plc, Mayne Pharma Group Ltd, Rusan Pharma Ltd, Trevena Inc, Teva Pharmaceutical Industries Ltd
Opioids are the broad group of medicine majorly used for relieving the pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Opioids Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Opioids Market – Key Market Dynamics
5.1 Opioids Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Chronic Pain Incidence
5.2.2 Increasing Geriatric Population
5.3 Market Restraints
5.3.1 Increasing Drug Abuse
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
5.6 Impact of Drivers and Restraints:
6. Opioids Market – Global Market Analysis
6.1 Opioids Market Revenue (US$ Million), 2022–2030
6.2 Opioids Market Forecast Analysis
7. Opioids Market Analysis – by Product
7.1 Immediate Release Short Acting Opioid
7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Immediate Release Short Acting Opioid
7.2 Extended Release Long-Acting Opioid
7.2.1 Overview
7.2.2 Extended Release Long-Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Extended Release Long-Acting Opioid
8. Opioids Market Analysis – by Application
8.1 Pain Management
8.1.1 Overview
8.1.2 Pain Management: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
8.2.1 Overview
8.2.2 Anesthesia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhoea Suppression
8.3.1 Overview
8.3.2 Diarrhoea Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
8.4.1 Overview
8.4.2 Cough Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
8.5.1 Overview
8.5.2 De-Addiction: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9. Opioids Market Analysis – by Route of Administration
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
9.3.1 Overview
9.3.2 Transdermal Patch: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10. Opioids Market Analysis – by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11. Opioids Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Opioids Market Overview
11.2.2 North America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Opioids Market – Revenue and Forecast Analysis – by Product
11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.3.1 North America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.2.3.2 North America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.2.3.3 North America: Opioids Market – Revenue and Forecast Analysis – by Application
11.2.4 North America: Opioids Market Breakdown, by Route of Administration
11.2.4.1 North America: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.2.4.2 North America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.5 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.1 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.2 United States: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.2.1 United States: Opioids Market Breakdown, by Product
11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.2.4 United States: Opioids Market Breakdown, by Application
11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
11.2.5.3 Canada: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
11.2.5.4 Mexico: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Opioids Market Overview
11.3.2 Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Europe: Opioids Market Breakdown, by Product
11.3.3.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Product
11.3.3.2 Europe: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.3.3.3 Europe: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.3.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Application
11.3.3.5 Europe: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.3.3.6 Europe: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.2 United Kingdom: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
11.3.4.3 Germany: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
11.3.4.4 France: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.4.1 France: Opioids Market Breakdown, by Product
11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.4.4 France: Opioids Market Breakdown, by Application
11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
11.3.4.5 Italy: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
11.3.4.6 Spain: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
11.3.4.7 Rest of Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Opioids Market Overview
11.4.2 Asia Pacific: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Product
11.4.2.2 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.4.2.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.4.2.4 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Application
11.4.2.5 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.6 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.2 China: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 China: Opioids Market Breakdown, by Product
11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.2.4 China: Opioids Market Breakdown, by Application
11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
11.4.3.3 Japan: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
11.4.3.4 India: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 India: Opioids Market Breakdown, by Product
11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.4.4 India: Opioids Market Breakdown, by Application
11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
11.4.3.5 South Korea: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
11.4.3.6 Australia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
11.4.3.7 Rest of APAC: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Opioids Market Overview
11.5.2 Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Product
11.5.2.2 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.5.2.3 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.5.2.4 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Application
11.5.2.5 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.6 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.2.7 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Country
11.5.2.8 Saudi Arabia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
11.5.2.9 South Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
11.5.2.10 United Arab Emirates: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
11.5.2.11 Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Opioids Market Overview
11.6.2 South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Product
11.6.2.2 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.6.2.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long Acting Opioid
11.6.2.4 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Application
11.6.2.5 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Route Of Administration
11.6.2.6 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.6.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.2 Brazil: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
11.6.3.3 Argentina: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
11.6.3.4 Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Opioids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Purdue Pharma LP
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Endo International plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mallinckrodt Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Collegium Pharmaceutical Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neuraxpharm Pharmaceuticals SL
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mayne Pharma Group Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rusan Pharma Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Trevena Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. Opioids Market Segmentation
Table 2. Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Product
Table 4. Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Immediate Release Short Acting Opioid
Table 5. Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Extended Release Long-Acting Opioid
Table 6. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 7. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Route of Administration
Table 8. Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 9. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 10. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 11. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 12. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 13. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 14. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 15. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 16. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 17. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 18. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 19. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 20. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 21. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 22. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 23. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 24. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 25. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 26. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 27. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 28. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 29. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 30. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 31. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 32. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 33. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 34. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 35. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 36. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 37. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 38. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 39. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 40. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 41. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 42. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 43. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 44. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 45. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 46. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 47. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 48. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 49. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 50. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 51. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 52. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 53. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 54. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 55. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 56. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 57. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 58. France: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 59. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 60. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 61. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 62. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 63. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 64. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 65. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 66. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 67. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 68. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 69. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 70. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 71. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 72. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 73. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 74. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 75. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 76. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 77. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 78. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 79. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 80. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 81. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 82. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 83. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 84. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 85. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 86. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 87. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 88. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 89. China: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 90. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 91. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 92. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 93. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 94. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 95. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 96. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 97. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 98. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 99. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 100. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 101. India: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 102. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 103. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 104. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 105. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 106. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 107. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 108. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 109. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 110. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 111. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 112. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 113. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 114. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 115. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 116. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 117. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 118. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 119. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 120. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 121. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 122. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 123. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 124. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 125. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 126. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 127. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 128. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 129. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 130. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 131. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 132. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 133. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 134. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 135. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 136. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 137. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 138. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 139. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 140. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 141. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 142. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 143. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 144. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 145. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 146. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 147. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 148. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 149. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 150. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 151. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 152. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 153. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 154. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 155. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 156. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 157. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 158. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 159. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 160. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 161. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 162. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 163. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 164. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 165. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 166. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long-Acting Opioid
Table 167. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 168. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 169. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 170. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 171. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Immediate Release Short Acting Opioid
Table 172. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Extended Release Long Acting Opioid
Table 173. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 174. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 175. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 176. Recent Organic Growth Strategies in Opioids Market
Table 177. Recent Inorganic Growth Strategies in the Opioids Market
Table 178. Glossary of Terms, Opioids Market
List of Figures
Figure 1. Opioids Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Opioids Market Revenue (US$ Million), 2022–2030
Figure 5. Opioids Market Breakdown by Geography, 2022 and 2030 (%)
Figure 6. Opioids Market Share (%) – by Product (2022 and 2030)
Figure 7. Immediate Release Short Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Extended Release Long-Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Opioids Market Share (%) – by Application (2022 and 2030)
Figure 10. Pain Management: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Anesthesia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Diarrhoea Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cough Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. De-Addiction: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Opioids Market Share (%) – by Route of Administration (2022 and 2030)
Figure 17. Oral: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Injectable: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Transdermal Patch: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Opioids Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 21. Hospital Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Opioids Market Breakdown by Region, 2022 and 2030 (%)
Figure 24. North America: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. North America: Opioids Market Breakdown, by Route of Administration (2022 and 2030)
Figure 26. North America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Europe: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 32. United Kingdom: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. Germany: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. France: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Italy: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. Spain: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Europe: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. Asia Pacific: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 40. China: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 41. Japan: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 42. India: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 43. South Korea: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 44. Australia: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 45. Rest of APAC: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. Saudi Arabia: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. South Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 49. United Arab Emirates: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 51. South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 52. South and Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Brazil: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 54. Argentina: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. Growth Strategies in Opioids Market
The List of Companies - Opioids Market
- Purdue Pharma LP
- Endo International plc
- Mallinckrodt Plc
- Collegium Pharmaceutical Inc
- Neuraxpharm Pharmaceuticals SL
- Hikma Pharmaceuticals Plc
- Mayne Pharma Group Ltd
- Rusan Pharma Ltd
- Trevena Inc
- Teva Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For